Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1991 1
1998 1
2001 1
2004 1
2009 1
2012 1
2014 1
2015 2
2016 1
2017 1
2018 2
2019 4
2020 1
2021 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean imanaka h[au] (300 results)?
Species Difference in Hydrolysis of an Ester-Type Prodrug of Levodopa in Human and Animal Plasma: Different Contributions of Alpha-1 Acid Glycoprotein.
Kono K, Nunoya KI, Nakamura Y, Bi J, Mukunoki A, Takeo T, Nakagata N, Maeda H, Yamaura Y, Imawaka H, Watanabe H, Maruyama T. Kono K, et al. Among authors: imawaka h. Mol Pharm. 2022 Sep 5;19(9):3450. doi: 10.1021/acs.molpharmaceut.2c00598. Epub 2022 Jul 28. Mol Pharm. 2022. PMID: 35900112 No abstract available.
Expanded Physiologically-Based Pharmacokinetic Model of Rifampicin for Predicting Interactions With Drugs and an Endogenous Biomarker via Complex Mechanisms Including Organic Anion Transporting Polypeptide 1B Induction.
Asaumi R, Menzel K, Lee W, Nunoya KI, Imawaka H, Kusuhara H, Sugiyama Y. Asaumi R, et al. Among authors: imawaka h. CPT Pharmacometrics Syst Pharmacol. 2019 Nov;8(11):845-857. doi: 10.1002/psp4.12457. Epub 2019 Sep 5. CPT Pharmacometrics Syst Pharmacol. 2019. PMID: 31420941 Free PMC article.
A Human Immortalized Cell-Based Blood-Brain Barrier Triculture Model: Development and Characterization as a Promising Tool for Drug-Brain Permeability Studies.
Ito R, Umehara K, Suzuki S, Kitamura K, Nunoya KI, Yamaura Y, Imawaka H, Izumi S, Wakayama N, Komori T, Anzai N, Akita H, Furihata T. Ito R, et al. Among authors: imawaka h. Mol Pharm. 2019 Nov 4;16(11):4461-4471. doi: 10.1021/acs.molpharmaceut.9b00519. Epub 2019 Oct 15. Mol Pharm. 2019. PMID: 31573814
Predicting successful/unsuccessful extrapolation for in vivo total clearance of model compounds with a variety of hepatic intrinsic metabolism and protein bindings in humans from pharmacokinetic data using chimeric mice with humanised liver.
Sawada T, Yamaura Y, Higuchi S, Imawaka H, Yamazaki H. Sawada T, et al. Among authors: imawaka h. Xenobiotica. 2020 May;50(5):526-535. doi: 10.1080/00498254.2019.1664791. Epub 2019 Sep 13. Xenobiotica. 2020. PMID: 31491346
Design and synthesis of new orally active inhibitors of human neutrophil elastase.
Ohmoto K, Okuma M, Yamamoto T, Kijima H, Sekioka T, Kitagawa K, Yamamoto S, Tanaka K, Kawabata K, Sakata A, Imawaka H, Nakai H, Toda M. Ohmoto K, et al. Among authors: imawaka h. Bioorg Med Chem. 2001 May;9(5):1307-23. doi: 10.1016/s0968-0896(01)00007-4. Bioorg Med Chem. 2001. PMID: 11377188
19 results